Extended-Release Quetiapine Maintained Antianxiety Effects

SHERRY BOSCHERT

doi:10.1016/s1097-8690(08)71201-0

Extended-Release Quetiapine Maintained Antianxiety Effects

Internal Medicine News ◽

10.1016/s1097-8690(08)71201-0 ◽

2008 ◽

Vol 41 (21) ◽

pp. 30

Author(s):

SHERRY BOSCHERT

Keyword(s):

Extended Release

1271: Effects of Darifenacin and Extended-Release Oxybutynin on Memory in Older Subjects

The Journal of Urology ◽

10.1016/s0022-5347(18)33484-0 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 409-409 ◽

Cited By ~ 2

Author(s):

Gary Kay ◽

Thomas Crook ◽

Ludmyla Rekeda ◽

Raul Lima

Keyword(s):

Extended Release ◽

Older Subjects

525: Effect of a Proton Pump Inhibitor on the Pharmacokinetics of Extended-Release Formulations of Oxybutynin and Tolterodine

The Journal of Urology ◽

10.1016/s0022-5347(18)37787-5 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 140-140

Author(s):

Scott MacDiarmid

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Extended Release ◽

Extended Release Formulations

1700: Efficacy of Extended-Release Doxazosin and Standard Doxazosin in Patients with Concomitant Benign Prostatic Hyperplasia and Sexual Dysfunction

The Journal of Urology ◽

10.1016/s0022-5347(18)35822-1 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 461-461

Author(s):

Roger S. Kirby ◽

Michael P. O'Leary ◽

Culley C. Carson

Keyword(s):

Benign Prostatic Hyperplasia ◽

Sexual Dysfunction ◽

Extended Release ◽

Prostatic Hyperplasia

Guanfacine Extended Release May Benefit ADHD

Pediatric News ◽

10.1016/s0031-398x(08)70065-1 ◽

2008 ◽

Vol 42 (2) ◽

pp. 28 ◽

Cited By ~ 1

Author(s):

ROBERT FINN

Keyword(s):

Extended Release

Abstract #100: Comparison of Extended-Release Metformin and Immediate-release Metformin

Endocrine Practice ◽

10.1016/s1530-891x(20)46372-4 ◽

2004 ◽

Vol 10 ◽

pp. 35

Author(s):

Mark Kipnes ◽

Robert M. Niecestro

Keyword(s):

Extended Release ◽

Immediate Release

Abstract #1141: Efficacy and Safety of Initial Combination Therapy with Canagliflozin (CANA) and Metformin Extended-Release (Met) in Drug-Naïve Patients with Type 2 Diabetes Mellitus (T2DM) By Latino/Hispanic Ethnicity

Endocrine Practice ◽

10.1016/s1530-891x(20)44270-3 ◽

2017 ◽

Vol 23 ◽

pp. 312

Author(s):

Jaime Davidson ◽

Julio Rosenstock ◽

Ujjwala Vijapurkar ◽

Michael Davies ◽

Anita Conner ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Extended Release ◽

Efficacy And Safety ◽

Initial Combination Therapy ◽

Drug Naïve ◽

Initial Combination

Abstract #273: Benefits of Extended Release Metformin: Systematic Review of the Ongoing Clinical Trials

Endocrine Practice ◽

10.1016/s1530-891x(20)44981-x ◽

2016 ◽

Vol 22 ◽

pp. 69

Author(s):

Hemant Thacker ◽

Rajeev Chawla ◽

Navneet Agrawal ◽

Rohit Kapoor ◽

Noel Somasundaram ◽

...

Keyword(s):

Systematic Review ◽

Clinical Trials ◽

Extended Release

Effectiveness of an extended release stimulant medication in treating preschool children with attention deficit hyperactivity disorder (The APS Study)

PsycEXTRA Dataset ◽

10.1037/e657832010-001 ◽

2010 ◽

Author(s):

John H. Fanton

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Medication ◽

Hyperactivity Disorder

P413 Chronic monotherapy with extended release metoprolol succinate normalizes mRNA gene expression for alpha and beta-myosin heavy chain isoforms in left-ventricular myocardium of dogs with heart failure

European Heart Journal ◽

10.1016/s0195-668x(03)93851-6 ◽

2003 ◽

Vol 24 (5) ◽

pp. 55

Author(s):

S RASTOGI

Keyword(s):

Gene Expression ◽

Heart Failure ◽

Extended Release ◽

Ventricular Myocardium ◽

Myosin Heavy Chain Isoforms ◽

Left Ventricular ◽

Left Ventricular Myocardium ◽

Metoprolol Succinate ◽

Mrna Gene ◽

Mrna Gene Expression

FDA Examines Extended-Release Opioids

Family Practice News ◽

10.1016/s0300-7073(05)71517-6 ◽

2005 ◽

Vol 35 (16) ◽

pp. 2

Author(s):

ALICIA AULT

Keyword(s):

Extended Release